Designing for the Whole Picture — Cala Health’s Deanna Harshbarger

Cala Health's FDA-cleared, non-invasive CaliKick IQ Plus device is now nationally available, backed by $50M in new funding.

• FDA clearance and launch: Cala Health's CaliKick IQ Plus system was FDA-cleared in April 2025 and became nationally available this week, alongside $50 million in funding from Trinity Capital.
• Non-invasive neuromodulation for tremor: The wrist-worn device treats essential tremor and Parkinson's action tremor by signaling the peripheral nervous system, targeting brain regions normally reached via deep brain stimulation (DBS).

Themes, sentiment and reasons are AI-written paraphrases, checked so they never quote an episode. They may contain errors. Not investment advice. Episodes remain the property of their creators.